Javier Martínez-García

Gene Therapy for Acquired and Genetic Cholestasis

G. González-Aseguinolaza, N. Weber, C. Smerdou, 2022, Biomedicines.

A minimal bile salt excretory pump promoter allows bile acid-driven physiological regulation of transgene expression from a gene therapy vector

G. González-Aseguinolaza, C. Smerdou, L. Odriozola, 2022, Cell & bioscience.

Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma

A. Patiño-García, M. Alonso, M. Zalacain, 2022, Molecular therapy oncolytics.

Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model

B. Bénichou, A. Douar, G. González-Aseguinolaza, 2019, Nature Communications.

Regulatory T Cells in Allergy and Asthma

E. Martín-Orozco, Javier Martínez-García, M. Norte-Muñoz, 2017, Front. Pediatr..

Reply to: "Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4-/- mouse model of PFIC3".

G. González-Aseguinolaza, N. Weber, Javier Martínez-García, 2021, Journal of hepatology.